|
EP400NL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62309999999222E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.408800E-04 |
| Normal-vs-Stage2 |
9.342200E-02 |
| Normal-vs-Stage3 |
2.223900E-02 |
| Normal-vs-Stage4 |
8.419600E-01 |
| Stage1-vs-Stage2 |
9.109600E-01 |
| Stage1-vs-Stage3 |
7.964200E-01 |
| Stage1-vs-Stage4 |
1.354830E-01 |
| Stage2-vs-Stage3 |
8.153000E-01 |
| Stage2-vs-Stage4 |
3.136000E-01 |
| Stage3-vs-Stage4 |
2.039000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.06540000050148E-07 |
| Normal-vs-AfricanAmerican |
2.251600E-01 |
| Normal-vs-Asian |
1.978390E-01 |
| Caucasian-vs-AfricanAmerican |
7.389300E-04 |
| Caucasian-vs-Asian |
4.386600E-01 |
| AfricanAmerican-vs-Asian |
6.648800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66048999999946E-05 |
| Normal-vs-Female |
8.985000E-04 |
| Male-vs-Female |
7.038600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.300230E-02 |
| Normal-vs-Extreme_Weight |
1.632450E-04 |
| Normal-vs-Obese |
2.504000E-03 |
| Normal-vs-Extreme_Obese |
2.474800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.690200E-01 |
| Normal_Weight-vs-Obese |
6.946600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.922600E-01 |
| Extreme_Weight-vs-Obese |
7.739600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.203000E-01 |
| Obese-vs-Extreme_Obese |
4.679400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.049800E-04 |
| Normal-vs-Age(41-60Yrs) |
2.3294000000007E-05 |
| Normal-vs-Age(61-80Yrs) |
1.019650E-04 |
| Normal-vs-Age(81-100Yrs) |
8.069800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.599200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.843400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.162300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.137200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.971600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.003840E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.48989999729332E-08 |
| Normal-VS-Type2 PRCC |
7.710200E-01 |
| Normal-VS-KIRP CIMP |
3.301200E-01 |
| Normal-VS-Unclassified PRCC |
1.475660E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.01620001302649E-09 |
| Type1 PRCC-VS-KIRP CIMP |
7.753900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.931600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.967200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.981370E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.631000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.777800E-03 |
| Normal-vs-N1 |
5.775600E-02 |
| Normal-vs-N2 |
4.636200E-01 |
| N0-vs-N1 |
5.541400E-01 |
| N0-vs-N2 |
6.515000E-01 |
| N1-vs-N2 |
5.952800E-01 |
|
|
